ANALYSIS OF EXPERIENCE OF USAGE NARCOTIC ANALGESICS IN SUBSTITUTION THERAPY FOR DRUG ADDICTS
https://doi.org/10.24884/2072-6716-2018-19-4-31-37
Abstract
The article analyzes and compares the risks associated with the usage of methadone and buprenorphine in substitution therapy. The main causes of death and statistical information on mortality from both drugs, as well as methods for the prevention and treatment of poisoning are indicated are pointed.
About the Authors
V. V. Shilov
North-Western State Medical University named after I. I. Mechnikov, St. Petersburg;
St. Petersburg I. I. Dzhanelidze Research Institute of Emergency Medicine, St. Petersburg
Russian Federation
Russian Federation
G. E. Guseynov
North-Western State Medical University named after I. I. Mechnikov, St. Petersburg
Russian Federation
Russian Federation
U. S. Yaburova
North-Western State Medical University named after I. I. Mechnikov, St. Petersburg
Russian Federation
Russian Federation
D. A. Shalygin
North-Western State Medical University named after I. I. Mechnikov, St. Petersburg
Russian Federation
Russian Federation
References
1. Ulezko T. A. Dezomorfinovaya narkomaniya. Narkologiya, 2011, No 10, рр. 54–57 (in Russ.)
2. Rukovodstvo po addiktologii / pod red. V. D. Mendelevicha. Saint Petersburg: Izdatel’stvo Rech’, 2007, 768 р. (in Russ.)
3. Batocyrenov B. V., Livanov G. A., Andrianov A. Yu. et al. Osobennosti klinicheskogo techeniya i korrekciya metabolicheskih rasstrojstv u bol’nyh s tyazhelymi otravleniyami metadonom. Obshchaya reanimatologiya, 2013, No 9, рр. 18–22 (in Russ.)
4. Ebert B. Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord // Neuroscience Letters. 1995. No 187. P. 165–168.
5. Peschanskih G. V., Chernyshev D. N. K voprosu o smertnosti ot narkotikov uchastnikov programm zamestitel’noj terapii v Evrope. Narkokontrol’, 2009, No 2, рр. 27–36 (in Russ.)
6. Hamilton R. Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition // Jones & Bartlett Learning. 2015. P. 13.
7. Connock M., Juarez-Garcia A., Jowett S. et al. Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic // Health technology assessment. 2007. No 11. P. 3–4.
8. Ivanec N. N. «Zamestitel’naya terapiya» narkomanii metadonom i drugimi opioidnymi narkotikami: proiskhozhdenie, sut’ i tendencii. Voprosy narkologii, 2004, No 2, рр. 3–7 (in Russ.)
9. Dave M., Rebecca M., Kamlesh P. The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales // BMJ Open. 2015. Vol. 5. e007629. doi:10.1136/ bmjopen-2015–007629
10. Shaffer H.J., LaSalvia T.A., Stein J. P. Comparing Hatha yoga with dynamic group psychotherapy for enhancing methadone maintenance treatment: a randomized clinical trial // Altern. Ther. Health Med. 1997. No 3. P. 57–66.
11. Lopez-Munoz F., Alamo C. The Consolidation of Neuroleptic Therapy: Janssen, the Discovery of Haloperidol and Its Introduction into Clinical Practice // Brain Research Bulletin. 2009. No 79. P. 130–141.
12. Matiyash O., Varban M. Ispol’zovanie naloksona kak sredstva snizheniya urovnya smertnosti ot peredozirovki opiatnymi narkotikami sredi potrebitelej in»ekcionnyh narkotikov. Nahodki. Praktika. Opyt v otvete na ehpidemiyu VICH, 2008, No 2, рр. 10–14 (in Russ.)
13. Heel R., Brogden R., Speight T. et al. Buprenorphine: a review of its pharmacological properties and therapeutic efficacy // Drugs. 1979. No 17. P. 81–110.
14. Shurova Eh. Eh., Belova M. V., Smirnov V. V. Metadon i metadonovaya terapiya. Razrabotka i registraciya lekarstvennyh sredstv, 2017, No 3, р. 198 (in Russ.)
15. Mendelson J., Upton R. A., Everhart E. T. Bioavailability of sublingual buprenorphine // Journal of Clinical Pharmacology. 1997. No 37. P. 31–37.
16. Nadezhdin A. V. O primenenie «zamestitel’noj terapii» u bol’nyh opioidnoj zavisimost’yu. Voprosy narkologii, 2001, No 5, рр. 66–70 (in Russ.)
17. Rudd R.A., Seth P., David F. et al. Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015 // MMWR Morb Mortal Wkly Rep. 2016. P. 1445–1452.
18. Grebenyuk A. A. K voprosu kachestva zhizni, svyazannogo so zdorov’em, u byvshih uchastnikov programmy zamestitel’noj podderzhivayushchej terapii. Narkologiya, 2016, No 2, рр. 45–48 (in Russ.)
19. Kursov S. V., Skoroplet S. N. Ostroe otravlenie opioidami. MNS, 2016, No 2, рр. 48–50 (in Russ.)
20. Nedashkovskij S. M., Kuchma Struk A. B. Ostraya pochechnaya nedostatochnost’ pri tyazhelyh otravleniyah metadonom. MNS, 2015, No 1, рр. 106–109 (in Russ.)
21. Arbuh D. M., Abuzarova G. R., Alekseeva G. S. Opioidnye anal’getiki v terapii bolevyh sindromov (chast’ 2). Vestnik anesteziologii i reanimatologii, 2017, No 14, рр. 61–71 (in Russ.)
22. Dolzhanskaya N. A., Egorov E. F., Har’kova N. V. Metadonovaya terapiya: obosnovanie primeneniya istoriya vnedreniya, ocenka ehffektivnosti. Voprosy narkologii, 1992, No 2, рр. 4–13 (in Russ.)
23. Lopez-Munoz F., Alamo C. The Consolidation of Neuroleptic Therapy: Janssen, the Discovery of Haloperidol and Its Introduction into Clinical Practice // Brain Research Bulletin. 2009. No 79. P. 130–141.
24. Afamgotov Eh. M. Bor’ba s nezakonnym oborotom narkotikov. Vestnik Adygejskogo gosudarstvennogo universiteta, 2012, No 3, рр. 9–13 (in Russ.)
Review
For citations:
Shilov V.V., Guseynov G.E., Yaburova U.S., Shalygin D.A. ANALYSIS OF EXPERIENCE OF USAGE NARCOTIC ANALGESICS IN SUBSTITUTION THERAPY FOR DRUG ADDICTS. EMERGENCY MEDICAL CARE. 2018;19(4):31-37. (In Russ.) https://doi.org/10.24884/2072-6716-2018-19-4-31-37
Views:
492
Email this article 